Alger Small Cap Growth Fund beats Russell 2000 Growth Index in Q2 2026

The Alger Small Cap Growth Fund's Class A shares outperformed the Russell 2000 Growth Index in the second quarter of 2026. Key contributors to this strong performance included Nebius Group, Astera Labs, and Twist Bioscience, while Insmed, Planet Fitness, and Forte Biosciences detracted from returns. This reflects Alger's active growth equity strategy focusing on innovation and disruption. Investors may watch how these holdings evolve as market conditions change.